WebApr 26, 2024 · Current therapy for PIMS-TS is based on anti-inflammatory treatment: intravenous immunoglobulin (first-line), intravenous glucocorticoids (second-line), or biological therapy (third-line; including interleukin [IL]-1 antagonists, IL-6 receptor blockers, and anti-tumour necrosis factor agents). WebApr 11, 2024 · PIMs have been associated with increased risk of hospitalization, worsening of physical function, and death in vulnerable populations, such as those with cognitive impairment, or in aged care and inpatient care. 4-8. This research focuses on PIMs in vulnerable populations creates an evidence gap.
Paediatric Inflammatory Multisystem Syndrome: …
WebAug 26, 2024 · Aug 26, 2024. Gianna Melillo. Researchers offer recommendations for addressing polypharmacy and potentially inappropriate medication (PIM) use among older patients with cancer. In a narrative ... WebApr 29, 2013 · A systematic review found that the use of PIMs was associated with a higher risk for hospitalization among community-dwelling older adults and possibly among … relocation planning
PIMS-TS in Intensive Care: Retrospective Cohort Trial (PIMS-TS INT)
WebMar 27, 2024 · Reducing potentially inappropriate medications (PIMs) in older adults is an area of sustained interest for many clinicians and researchers across the globe, as PIMs … WebThe prevalence of PIMs and POMs and subsequent follow-up in older patients with cancer is high. A pharmacist-led comprehensive medication review is a good instrument to identify these PIMs and POMs and to optimize patients' treatment. A complete approach, including pharmacists' expert opinion, is re … WebJan 4, 2012 · Alpha-1 antitrypsin deficiency (AATD) is an inherited condition that causes low levels of, or no, alpha-1 antitrypsin (AAT) in the blood. AATD occurs in approximately 1 in 2,500 individuals. This condition is found in all ethnic groups; however, it occurs most often in whites of European ancestry. Alpha-1 antitrypsin (AAT) is a protein that is ... relocation planners tom hambly